François Laliberté

Real-world comparative effectiveness and safety of rivaroxaban and warfarin in nonvalvular atrial fibrillation patients

François Laliberté, Michel Cloutier, Winnie W. Nelson et al. · Current Medical Research and Opinion · 2014 · 185 citations

Current practice patterns and patient persistence with anticoagulant treatments for cancer‐associated thrombosis

Alok A. Khorana, Keith R. McCrae, Dejan Milentijevic et al. · Research and Practice in Thrombosis and Haemostasis · 2017 · 136 citations · Full text

Impact of Daily Dosing Frequency on Adherence to Chronic Medications Among Nonvalvular Atrial Fibrillation Patients

François Laliberté, Winnie W. Nelson, Patrick Lefèbvre et al. · Advances in Therapy · 2012 · 122 citations

Health Policy, Cardiovascular Disease, Daily Dosing Frequency +8

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy

François Laliberté, Katherine Dea, Mei Sheng Duh et al. · Menopause The Journal of The North American Menopause Society · 2011 · 111 citations

Impact of Early Versus Late Systemic Lupus Erythematosus Diagnosis on Clinical and Economic Outcomes

Alan Oglesby, Caroline Korves, François Laliberté et al. · Applied Health Economics and Health Policy · 2014 · 98 citations

Rheumatology, Economic Outcomes, Systemic Lupus Erythematosus +10